MALIN CORPORATION PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.7 EUR | -.--% |
|
-3.39% | +26.67% |
| 01/05 | Malin Corp investee signs agreement with Astellas Pharma | AN |
| 28/03 | Transcript : Malin Corporation plc - Shareholder/Analyst Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MALIN CORPORATION PLC | Other Pharmaceuticals | -.--% | -3.39% | +26.67% | +18.75% | +22.32% | 12Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MLC Stock
- Charts Malin Corporation plc
- Comparison Chart
